4TINDALL WN, BOLTRI JM, WILHELM SM. Mild-to-moderate ulcerative colitis : your role in patient compliance and health care costs[J]. J Manag Care Pharm, 2007, 13(7 Suppl A): S2-S12.
5SINGER MV, SCHMAUSSER H, SCHONFELD G. Efficacy and tolerability of olsalazine (dipentum) in the treatment of patients with ulcerative colitis-results of a field study[J]. Hepatogastroenterotogy, 2006, 53(69): 317-321.
